ERD

PARC | Partnership for the Assessment of Risks from Chemicals

01-05-2022

-

30-04-2029

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

EOSC-Life | Providing an open collaborative space for digital biology in Europe

01-03-2019

-

31-08-2023

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

CORBEL | Coordinated Research Infrastructures Building Enduring Life-science services

01-09-2015

-

31-05-2020

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

01-01-2016

-

31-12-2021

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

01-09-2016

-

31-08-2023

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

01-10-2023

-

31-03-2028

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

REMEDI4ALL | BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL

01-09-2022

-

31-08-2027

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

TClock4AD | Targeting Circadian Clock Dysfunction in Alzheimer’s Disease

01-03-2023

-

28-02-2027

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

01-04-2024

-

31-03-2029

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

EATRIS-CONNECT | EATRIS-CONNECT

01-05-2024

-

30-04-2027

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

AiChemist | Explainable AI for Molecules - AiChemist

01-09-2023

-

31-08-2027

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

OBERON | An integrative strategy of testing systems for identification of EDs related to metabolic disorders

01-01-2019

-

30-06-2024

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

EUREST-RISE | European Regulatory Science on Tobacco - Research and Innovation Staff Exchange

01-06-2021

-

31-05-2025

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

ESCAPE-NET | European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment

01-01-2017

-

31-12-2022

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

PERMIT | PERsonalised MedicIne Trials

01-01-2020

-

30-06-2022

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

UNITI | Unification of treatments and Interventions for Tinnitus patients

01-01-2020

-

30-09-2023

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

I3LUNG | Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy

01-06-2022

-

31-05-2027

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

ENTRAIN | ENdoThelial macRophage Alliance In Neuroinflammation

01-05-2019

-

30-04-2023

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

ONTOX | Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment

01-05-2021

-

30-04-2026

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

TackSHS | Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project.

01-11-2015

-

31-10-2019

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

NEPHSTROM | Novel Stromal Cell Therapy for Diabetic Kidney Disease

01-05-2015

-

31-10-2021

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

SECURE | Secondary prEvention of CardiovascUlaR disease in the Elderly trial

01-05-2015

-

31-12-2021

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

NanoCarb | Glyco-Nanoparticles for Applications in Advance Nanomedicine

01-10-2018

-

31-03-2023

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

in3 | An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment

01-01-2017

-

30-06-2021

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

nPETS | NANOPARTICLE EMISSIONS FROM THE TRANSPORT SECTOR: HEALTH AND POLICY IMPACTS

01-06-2021

-

30-11-2024

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

OSIRIS | Open Science to Increase Reproducibility in Science

01-01-2023

-

31-12-2026

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

BBDiag | Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease

01-01-2017

-

31-12-2021

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

PEPTICAPS | Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications

05-10-2015

-

04-10-2018

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

CCE_DART | Building Data Rich Clinical Trials

01-02-2021

-

31-01-2025

Show more information

Organisation ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

Projects overview

Selected filters:

PARC | Partnership for the Assessment of Risks from Chemicals

EOSC-Life | Providing an open collaborative space for digital biology in Europe

CORBEL | Coordinated Research Infrastructures Building Enduring Life-science services

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

REMEDI4ALL | BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL

TClock4AD | Targeting Circadian Clock Dysfunction in Alzheimer’s Disease

RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

EATRIS-CONNECT | EATRIS-CONNECT

AiChemist | Explainable AI for Molecules - AiChemist

OBERON | An integrative strategy of testing systems for identification of EDs related to metabolic disorders

EUREST-RISE | European Regulatory Science on Tobacco - Research and Innovation Staff Exchange

ESCAPE-NET | European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment

PERMIT | PERsonalised MedicIne Trials

UNITI | Unification of treatments and Interventions for Tinnitus patients

I3LUNG | Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy

ENTRAIN | ENdoThelial macRophage Alliance In Neuroinflammation

ONTOX | Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment

TackSHS | Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project.

NEPHSTROM | Novel Stromal Cell Therapy for Diabetic Kidney Disease

SECURE | Secondary prEvention of CardiovascUlaR disease in the Elderly trial

NanoCarb | Glyco-Nanoparticles for Applications in Advance Nanomedicine

in3 | An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment

nPETS | NANOPARTICLE EMISSIONS FROM THE TRANSPORT SECTOR: HEALTH AND POLICY IMPACTS

OSIRIS | Open Science to Increase Reproducibility in Science

BBDiag | Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease

PEPTICAPS | Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications

CCE_DART | Building Data Rich Clinical Trials